fda warning letters compounded semaglutide tirzepatide september 2025 NCL Issues a Second Alert to Heed Warnings About Unregulated Versions of GLP-1 Weight Loss Drugs Congress Introduces SAFE Drugs Act

The primary concern relates to aspiration risk

A Facility Booking Fee will be charged prior to day of procedures for all excisions and biopsies, please ask reception

Tirzepatide is a dual-action medication that targets both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors

Gut-supportive probiotics: The gut plays a direct role in hormone balance through the estrobolome, a group of bacteria involved in estrogen metabolism

If approved, retatrutide may become part of a wider set of treatment options for people who need more support with weight management and related health concerns

Never discontinue Ozempic without consulting your GP or prescribing clinician, as this may affect your blood glucose control